For APPA members, manufacturing strategy has never been more complex. The pet industry continues to grow and evolve, yet companies are making decisions in an environment defined by shifting trade rules, capacity constraints, and rapidly changing consumer expectations.
Despite that volatility, there are real opportunities for pet product manufacturers, suppliers, and brand owners who approach this moment with a long-term, data-driven lens.
In our recent Trade Talks discussion, APPA’s trade experts emphasized a hard reality: simply “bringing manufacturing back to the U.S.” is not as straightforward as it sounds. For many pet categories, the barriers are structural, not just financial.
From the manufacturing side, Rebecca highlighted that it is highly category-specific:
As a result, most APPA members are not executing a clean “all-in” reshoring move. Instead, they are:
For pet companies, the operational takeaway is clear: manufacturing strategy must balance tariff exposure with the realities of global capacity, lead times, and labor availability. A diversified, multi-country sourcing model is often more realistic than a complete reshoring play.
The good news: underlying demand for pet products remains a major tailwind.
APPA’s 2025 State of the Industry Report shows that Gen Z and younger Millennial pet owners are driving new pet acquisition, even while acknowledging economic pressure. Many say the emotional and lifestyle benefits of pets outweigh financial concerns, and Gen Z was the most likely generation to bring home a new pet.
That has several implications for manufacturers and suppliers:
On top of that, trends like pet-friendly workplaces are opening new commercial channels, office-ready pet products, B2B bundles, and corporate gifting and wellness programs that treat pets as part of the employee experience.
Taken together, this means that manufacturing decisions are not being made in a vacuum of cost alone. They must also support:
While trade policy has introduced complexity, tax policy is simultaneously creating new incentives to invest in U.S.- based production.
According to TaxFoundation.org Under the One Big Beautiful Bill Act (OBBBA) and related tax changes, manufacturers can now take advantage of significantly more generous expensing rules:
For pet companies that do have the capacity and capital to invest domestically, whether in manufacturing their own products, building co-packing infrastructure, or partnering with U.S. converters and contract manufacturers, these rules can:
However, these incentives are time-bound and complex. They require careful planning around:
For APPA members, this is a moment to put tax, finance, operations, and supply-chain leaders in the same room and ask:
“If we ever wanted to build or expand capacity closer to home, is now the optimal window to do it?”
In this environment, the most resilient pet companies are:
1. Running scenario-based sourcing plans
Modeling different combinations of countries, partners, and product mixes rather than betting on a single “all-in” location.
2. Aligning manufacturing with demand trends
Designing capacity and capabilities around Gen Z, multi-pet households, and workplace pet trends not just historical volume patterns.
3. Leveraging incentives, not chasing them
Treating tax and policy incentives (like expensing) as accelerators of sound business strategy, not as the sole driver of plant decisions.
4. Building flexibility into contracts and product design
Shorter contract terms, modular product architectures, and more interchangeable materials and packaging can all help companies pivot as conditions change.
Manufacturing in today’s pet industry is not about finding a single “right” answer. It is about designing a resilient system, one that can adapt to shifting trade rules, leverage new investment incentives, and still deliver the innovation, value, and quality today’s pet families expect.
Disclaimer: APPA does not make any representations about the completeness, suitability, or adequacy of the information provided in this blog. Any information provided are intended for general informational purposes only, they do not constitute a recommendation or solicitation to do or omit to do any action and should not be interpreted as legal, regulatory, or compliance advice. You should seek independent advice from qualified professionals before acting on any information provided and/or to evaluate specific regulatory obligations and operational decisions.